New patent for Gilead Sciences drug BIKTARVYBy DrugPatentWatch – Make Better Decisions / March 22, 2024 Annual Drug Patent Expirations for BIKTARVY Biktarvy is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from two suppliers. There are twelve…Source